Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 39.80 Billion |
| USD 145.70 Billion | |
| % | |
|
Global Dupuytren’s Disease Market, By Treatment (Surgery, Radiation Therapy, Needle Aponeurotomy, Steroid Shot, Enzyme Injection, Occupational Therapy, Others), Diagnosis (Physical Examination, X-Ray, Others), Dosage (Injection, Tablets, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Industry Trends and Forecast to 2030.
Get Exclusive Sample Copy of this Report Here
The increasing prevalence acts as one of the major factors driving the growth of global dupuytren’s disease market. The advancements in medical technology and increasing health care infrastructure expenditure accelerate the global dupuytren’s disease market growth. The disease's rising prevalence is driving considerable growth in the market. According to a recent study published in the Journal of Hand Surgery, there has been a significant increase in diagnosed cases, indicating a larger patient population in need of treatment alternatives. As a result, pharmaceutical firms and medical device makers have boosted their spending in research and development to fulfil the demand for better management techniques. Furthermore, a 2021 population study in the United States discovered that up to 7% of the population had clinical symptoms, with more than one-third of that group afflicted by the impact of dupuytren's contractures on everyday function.
Data Bridge Market Research analyses that the global dupuytren’s disease Market which was USD 39.8 billion in 2022, is expected to reach USD 145.7 billion by 2030, and is expected to undergo a CAGR of 22.20% during the forecast period of 2023 to 2030. “Surgery, Radiation Therapy” segment dominates the treatment segment of the global dupuytren’s disease market owing to the advancements in technology have led to the development of advancements in drug products for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Treatment (Surgery, Radiation Therapy, Needle Aponeurotomy, Steroid Shot, Enzyme Injection, Occupational Therapy, Others), Diagnosis (Physical Examination, X-Ray, Others), Dosage (Injection, Tablets, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Merck & Co., Inc. (U.S.), Fresenius Kabi AG (Germany.), Bristol-Myers Squibb Company (U.S.), Endo International plc (Ireland.), Pfizer Inc. (U.S.), Hikma Pharmaceuticals PLC (U.S.), Spear Pharmaceuticals. (U.S.), Actiza Pharmaceutical Private Limited (India.), Nantong Jinghua Pharmaceutical Co., Ltd. (U.S.), GSK plc (U.S.), Abbott (U.S.), Bayer AG(U.S.), AstraZeneca (U.S.), Johnson & Johnson Services Ltd. (U.S.), Cipla Inc. (U.S.), LEO Pharma A/S (U.S.), Sumitomo Dainippon Pharma Co., Ltd. (Japan.), Novartis AG(U.S.), Sanofi (France), Aurobindo Pharma (India), and Lupin (India)
|
|
Market Opportunities
|
|
Market Definition
Dupuytren's disease, also known as dupuytren's contracture, is a progressive condition that affects the hand and fingers. It is characterized by the thickening and tightening of the connective tissue called the palmar fascia, which lies beneath the skin of the palm and fingers. This fibrous tissue forms nodules and cords that can gradually contract, leading to the curling and bending of the affected fingers towards the palm.
Drivers
The prevalence of dupuytren's disease is rising globally, particularly in aging populations. Factors such as genetics, gender, and certain lifestyle choices contribute to its development. The growing number of affected individuals creates a significant market demand for effective treatments
Improvements in diagnostic techniques, including imaging technologies and biomarker identification, have facilitated early and accurate detection of dupuytren's disease. Early diagnosis allows for timely intervention and treatment, driving the demand for effective therapies.
The field of dupuytren's disease treatment has witnessed technological advancements, leading to the development of novel and minimally invasive treatment options. Procedures such as needle aponeurotomy, collagenase injection, and radiotherapy have gained popularity, offering alternatives to traditional surgical approaches. These advancements provide patients with more treatment choices, driving market growth.
Opportunities
Increasing awareness about dupuytren's disease among patients, healthcare professionals, and the general population has contributed to the diagnosis and treatment-seeking behaviour Educational initiatives, patient support groups, and online resources have played a crucial role in enhancing awareness and driving market growth
Many patients prefer non-surgical interventions that are less invasive, have shorter recovery times, and offer comparable outcomes to traditional surgical procedures. The development of non-surgical treatments such as injectable collagenase has gained traction and is expected to drive market growth.
Restraints/Challenges
One of the significant challenges is the limited awareness and understanding of Dupuytren's disease among the general population and even some healthcare professionals. This can lead to delays in diagnosis and treatment, as well as underreporting of the condition.
Dupuytren's disease can often be misdiagnosed or overlooked, especially in its early stages. Its symptoms, such as nodules or thickened cords in the palm, can be mistaken for other conditions or considered insignificant. This can result in delayed intervention and progression of the disease.
This global dupuytren’s disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global dupuytren’s disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
The global dupuytren’s disease market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
Diagnosis
Dosage
Route of Administration
End Users
The global dupuytren’s disease market is analysed and market size insights and trends are the basis treatment, diagnosis, dosage, route of administration, end users as referenced above.
The countries covered in the global dupuytren’s disease market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa
North America dominates the global dupuytren’s disease market due to the presence of major key players, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region.
Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The global dupuytren’s disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global dupuytren’s disease market.
Some of the major players operating in the ssglobal dupuytren’s disease market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.